As of 2024-12-12, the Relative Valuation of Allovir Inc (ALVR) is (19.99) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.51 USD, the upside of Allovir Inc based on Relative Valuation is -4058.2%.
The range of the Relative Valuation is (18.71) - (17.47) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 21.6x - 31.4x | 26.5x |
| Forward P/E multiples | 19.1x - 20.1x | 19.6x |
| Fair Price | (18.71) - (17.47) | (19.99) |
| Upside | -3805.8% - -3558.5% | -4058.2% |
| Date | P/E |
| 2024-11-29 | -0.63 |
| 2024-11-27 | -0.62 |
| 2024-11-26 | -0.62 |
| 2024-11-25 | -0.63 |
| 2024-11-22 | -0.63 |
| 2024-11-21 | -0.66 |
| 2024-11-20 | -0.66 |
| 2024-11-19 | -0.64 |
| 2024-11-18 | -0.67 |
| 2024-11-15 | -0.66 |
| 2024-11-14 | -0.64 |
| 2024-11-13 | -0.65 |
| 2024-11-12 | -0.62 |
| 2024-11-11 | -0.85 |
| 2024-11-08 | -0.71 |
| 2024-11-07 | -1.13 |
| 2024-11-06 | -1.16 |
| 2024-11-05 | -1.14 |
| 2024-11-04 | -1.02 |
| 2024-11-01 | -1.10 |
| 2024-10-31 | -1.07 |
| 2024-10-30 | -1.02 |
| 2024-10-29 | -1.03 |
| 2024-10-28 | -0.99 |
| 2024-10-25 | -0.93 |
| 2024-10-24 | -0.91 |
| 2024-10-23 | -0.88 |
| 2024-10-22 | -0.90 |
| 2024-10-21 | -0.89 |
| 2024-10-18 | -0.89 |
| 2024-10-17 | -0.89 |
| 2024-10-16 | -0.92 |
| 2024-10-15 | -0.90 |
| 2024-10-14 | -0.98 |
| 2024-10-11 | -0.97 |
| 2024-10-10 | -0.94 |
| 2024-10-09 | -0.93 |
| 2024-10-08 | -0.91 |
| 2024-10-07 | -0.92 |
| 2024-10-04 | -0.91 |
| 2024-10-03 | -0.94 |
| 2024-10-02 | -0.95 |
| 2024-10-01 | -0.94 |
| 2024-09-30 | -0.93 |
| 2024-09-27 | -0.92 |
| 2024-09-26 | -0.90 |
| 2024-09-25 | -0.89 |
| 2024-09-24 | -0.88 |
| 2024-09-23 | -0.90 |
| 2024-09-20 | -0.88 |